STOKE SURGERY — All Prescriptions & Medications — Page 10
Practice Code: L83071 | PLYMOUTH, PL3 4DP
Showing results 451-500 of 590
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Ranolazine | 21 | 1,535 | £271 | -87.6% ▼ |
| Midodrine hydrochloride | 21 | 3,672 | £885 | -56.9% ▼ |
| Clonidine hydrochloride | 21 | 3,752 | £364 | -60.6% ▼ |
| Carbimazole | 21 | 970 | £40 | -81.4% ▼ |
| Potassium chloride | 21 | 440 | £47 | +12.3% ▲ |
| 21 | 330 | £320 | +233.1% ▲ | |
| 21 | 880 | £623 | -36.5% ▼ | |
| Prucalopride | 20 | 546 | £376 | -48.6% ▼ |
| Dexamfetamine sulfate | 20 | 1,288 | £1.9K | -44.4% ▼ |
| Naltrexone hydrochloride | 20 | 140 | £321 | +40.9% ▲ |
| Erythromycin | 20 | 1,804 | £408 | -42.3% ▼ |
| Ciprofloxacin | 20 | 583 | £39 | -49.9% ▼ |
| RtS 2.4 kcal/ml m/sk lower volume, higher protein (0913011) | 20 | 50.3K | £1.0K | -71.4% ▼ |
| Acetazolamide | 20 | 1,414 | £55 | -7.7% ▼ |
| 20 | 400 | £902 | -49.2% ▼ | |
| 20 | 100 | £311 | +143.7% ▲ | |
| Citalopram hydrochloride | 19 | 285 | £196 | +18.4% ▲ |
| Cinnarizine | 19 | 1,562 | £73 | -59.4% ▼ |
| Olopatadine | 19 | 165 | £159 | -56.7% ▼ |
| Light liquid paraffin | 19 | 7,400 | £236 | -44.2% ▼ |
| 19 | 299 | £360 | -72.3% ▼ | |
| 19 | 1,805 | £4.0K | -52.4% ▼ | |
| 19 | 3,200 | £647 | +100.5% ▲ | |
| Naratriptan hydrochloride | 18 | 276 | £53 | -31.2% ▼ |
| Alprostadil | 18 | 82 | £1.1K | +5.2% ▲ |
| Powder fibre fortifier (0913151) | 18 | 5,528 | £307 | +131.6% ▲ |
| Etodolac | 18 | 602 | £297 | -35.0% ▼ |
| Betamethasone sodium phosphate | 18 | 190 | £42 | -30.5% ▼ |
| Atropine sulfate | 18 | 870 | £711 | +41.3% ▲ |
| Enoxaparin | 17 | 322 | £2.0K | -17.1% ▼ |
| Varenicline tartrate | 17 | 530 | £505 | +71.7% ▲ |
| Rifaximin | 17 | 238 | £1.1K | -36.7% ▼ |
| Leflunomide | 17 | 600 | £39 | -55.1% ▼ |
| Ketoprofen | 17 | 850 | £37 | -52.6% ▼ |
| Emollient bath and shower preparations | 17 | 8,100 | £113 | -72.9% ▼ |
| Tars | 17 | 4,200 | £278 | +102.8% ▲ |
| 17 | 1,097 | £237 | -80.0% ▼ | |
| 17 | 41 | £239 | -38.9% ▼ | |
| 17 | 17 | £90 | -66.9% ▼ | |
| 17 | 130 | £268 | +16.4% ▲ | |
| 17 | 980 | £720 | +28.0% ▲ | |
| 17 | 630 | £3.1K | +34.4% ▲ | |
| Dosulepin hydrochloride | 16 | 224 | £47 | -71.7% ▼ |
| Reboxetine | 16 | 896 | £270 | +3.9% ▲ |
| Ethosuximide | 16 | 2,072 | £3.5K | +8.5% ▲ |
| Mebendazole | 16 | 644 | £34 | +39.8% ▲ |
| Exemestane | 16 | 700 | £145 | -50.8% ▼ |
| Water for injection | 16 | 212 | £84 | -52.7% ▼ |
| Sodium fluoride | 16 | 918 | £109 | -51.8% ▼ |
| Pdr 3.8 - 4.9 kcal/g energy (carbohyd) fortifier (0913142) | 16 | 12.8K | £295 | +100.9% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.